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1. Introduction 
Despite unprecedented scale up and advances in the treatment of HIV/AIDS in the last 
fifteen years, the great majority of individuals around the world who need antiretroviral 
therapy (ART) are not receiving it. Furthermore, it has now become apparent that even in 
locations where there is access to treatment, segments of the population do not engage in 
care because of multiple barriers that prevent them from accessing care, thus losing the 
potential benefits of ART. A social ecological framework can be applied to understand the 
multiple layers of factors at the individual, interpersonal and structural levels, that affect 
HIV clinical outcomes and consequently transmission (Stokols 1996). The institutional 
barriers include those imposed by the very institutions developed to care for people with 
HIV. Beyond institutional barriers, factors related to poverty and economics, politics, and 
the sociocultural and psychological context of the individual all contribute to the challenges 
faced by people seeking treatment.   
Acknowledging the difficulties that HIV-infected individuals confront, the World Health 
Organization (WHO) has put forth the goal of universal access to HIV/AIDS prevention, 
treatment, and care (WHO 2010). In addition to improving the individual’s personal health, 
access and treatment with subsequent virologic suppression on a population level may help 
decrease transmission of HIV (Das et al. 2010). Until a cure for HIV is found, individuals 
infected with HIV face a lifetime of requiring health care access and antiretroviral drug 
therapy to control the virus, in addition to the comorbidities associated with chronic HIV 
infection.     
For those able to enter and remain in care, additional obstacles can prevent them from 
maintaining high levels of adherence to the available therapies. In this chapter, we will 
explore how the sociocultural context of a particular region can influence health care 
outcomes for individuals living with HIV. First, we exemplify two epidemics and two health 
care systems separated geographically and culturally from one another, Atlanta, Georgia, 
United States, and Durban, KwaZulu-Natal, South Africa, in order to illustrate how these 
factors can impede a successful response to ART. Following this description, we describe 
efforts that have been undertaken to address some of these barriers to improve engagement 
in health care within and beyond these settings. We also review creative approaches that can 
be used to maximize adherence to treatment. Finally, a course for the ultimate way forward 
is chartered, detailing steps necessary to address these barriers in a variety of settings 
around the world.  
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2. Atlanta, Georgia, USA 
2.1 The city too busy to hate  
Atlanta is located in the northwest corner of the state of Georgia, which is in the 
southeastern region of the US. Atlanta was incorporated in 1847 and began as a railroad 
hub, connecting multiple cities across the US. During the American Civil War (1861-1865), 
the city was set on fire, destroying a large percentage of its infrastructure. In the years 
following the Civil War, the city was rebuilt gradually, with the intention to create a modern 
city that was less reliant on agriculture than previously. For example, the Georgia Institute 
of Technology, a prominent science and engineering university, was founded in 1885 in 
order to advance these goals (The New Georgia Encyclopedia). In addition, two historically 
black colleges, Spellman College (for women) and Morehouse College (for men) were 
established soon after the Civil War. 
As the population of Atlanta expanded significantly in the wake of the Civil War, tensions 
between blacks and whites grew, and Jim Crow laws supporting segregation of the races in 
housing, school, and socialization began to take effect. In 1906, on the backdrop of Georgia’s 
gubernatorial race which highlighted racial segregation and after newspapers reported 4 
incidents of alleged sexual abuse of white women by black men, Atlanta’s first documented 
race riot occurred. The death toll for the event was approximately 25 to 40 African-
Americans and 2 whites. After 3 days of fighting, city officials, prominent clergy, and 
newspapers proposed an end to the violence. White and black community and business 
leaders came together to support racial reconciliation, in order to protect Atlanta’s image as 
a “thriving New South City.” As a result of these efforts, Atlanta did not feature as a major 
city for civil rights infringement during the riots in the 1960s throughout the south. 
Furthermore, Atlanta has a strong historical connection with the Civil Rights movement of 
the mid-twentieth century, because Martin Luther King, Jr., preached at the Ebenezer 
Baptist Church, located in downtown Atlanta, and the city was seen as a major organizing 
center for students and other civil rights leaders (The New Georgia Encyclopedia). 
Atlanta currently has a population of approximately 500,000 within the city limits, and 5 
million in the entire metropolitan statistical area (MSA), which includes 31 counties.  The 
racial makeup of the city is approximately 50% African-American, 43% Caucasian, 13% 
Asian, and 5% Hispanic. In comparison, as of 2009 the state of Georgia’s population was 
estimated to be 9.8 million, consisting of 65% white and 30% black (United States Census).  
Atlanta’s population has grown considerably after the opening of Hartsfield-Jackson 
International Airport in 1980 (which is one of the busiest in the US) (Yee 2007) and the 
hosting of the Summer Olympics in 1996. Twenty percent of the population lives below the 
poverty level. Major industries in Atlanta include professional and administrative services, 
waste management, education, arts, and food services (United States Census). Savannah, 
located on the Atlantic Ocean, is the second largest port eastern seaboard of the US and 
serves as a major hub for international shipping. Much of this traffic moves through Atlanta 
as it passes on to other cities throughout the country. Atlanta has a confluence of racial and 
ethnic diversity, industry, high-quality colleges and universities, and trade that give it a 
uniquely metropolitan feel in this region.  
2.2 HIV Epidemic in Atlanta and the southeastern U.S. 
According to surveillance statistics for HIV/AIDS, the southeast has been among the most 
significantly affected regions in the US since 2005. Georgia ranked 8th in the nation for its 
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reported prevalence rate of AIDS, and a substantial proportion of HIV cases in this region is 
diagnosed in Atlanta. The same factors that contribute to high rates of infection and 
advanced disease in this region also lead to poor entry and retention in care. These factors 
include poverty (9th most poor state in US), inadequate education (8th worst high school 
graduation rate in the US), substance abuse, poor access to health care, food insufficiency 
(Kalichman et al. 2010), and child sex trade (Longerbeam 2010). In Atlanta, crack cocaine use 
and homelessness impact transmission of HIV, but there is also significant transmission 
among heterosexuals and men who have sex with men (MSM).  
It is important to point out that while 78% of HIV (non-AIDS) cases and 75% of AIDS 
cases diagnosed in 2008 in Georgia were among Blacks, they make up only 30% of the 
state population (Mangla and Gant 2008). Among cases of HIV/AIDS diagnosed in 
Georgia in 2008, about half (53%) occurred between the ages of 30 and 49, one quarter 
(28%) between ages 20 and 29, and 14% among people 50 years of age of older (Mangla 
and Gant 2008).  
The Atlanta eligible metropolitan area (EMA) is a 20-county region designated by the US 
Department of Health and Human Services (DHHS) Health Resources and Services 
Administration (HRSA) to receive federal funding through the Ryan White Comprehensive 
AIDS Resources Emergency (CARE) Act. As of the end of 2009, a total of 26,546 persons 
were living with HIV/AIDS in the 20-county Atlanta EMA; of these, 15,548 were AIDS cases 
and 10,998 are HIV-infected but do not yet have AIDS (eHARS Reporting System 2010). The 
racial distribution is 68% among blacks and 24% among whites (eHARS Reporting System 
2010). The majority of cases are among men, and the main risk factor for transmission is 
MSM (46%), followed by heterosexual contact (8.4%), injection drug use (7.3%) (eHARS 
Reporting System 2010).    
Within the city of Atlanta, HIV is largely concentrated in one large cluster located in 
downtown and southwest Atlanta that consists of 157 census tracts and covers about 180 
square miles. The cluster contains 60% of prevalent HIV/AIDS cases in the Atlanta MSA, 
and the HIV prevalence within the cluster is 1.34% compared to 0.32% outside the cluster 
(Hixson et al. 2011). Thus, as a whole, the city of Atlanta has a “generalized epidemic” with 
an HIV prevalence of >1% (see Figure 1). 
3. Durban, KwaZulu-Natal, South Africa 
3.1 The city of gold 
Durban (eThekwini), located on the eastern coast of the Republic of South Africa, is the 
largest city in the province of KwaZulu-Natal (KZN). A well-known tourist destination for 
South Africans and international travelers, Durban is the third largest city in the Republic 
and one of the busiest seaports in the southern hemisphere. Durban has a population of 
nearly 3,500,000 including nearby townships. A very culturally diverse community, 
Durban’s population is 68% black African, 20% Asian (one of the largest Indian populations 
outside of India and largest Asian community on the African continent), 9% white, and 3% 
coloured. Manufacturing, tourism, finance and transport are the major industrial sectors in 
the city. A recent principal host city for the 2010 Fédération Internationale de Football 
Association World Cup, eThekwini boasts the highest credit rating in Africa for a 
municipality in September 2004. 
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Fig. 1. HIV prevalence estimates for city of Atlanta and Fulton, DeKalb, Gwinnett, and 
Clayton counties, 2008 (Produced from Georgia Department of Public Health surveillance 
data) 
The aboriginal population of KZN was believed to have settled in the area around 100,000 
BC and was eventually overtaken by the Bantu expansion in 300 AD. Early exploration by 
the Portuguese began in the 15th century (Russell 1899). The Dutch and British later formed 
more lasting settlements on the coast. The peaceful relationship between the Kingdom of 
Shaka Zulu and the early British settlers was disrupted after tensions developed between 
colonists and native Africans (Bulpin 1977). This was followed by major conflicts known as 
the Anglo-Zulu (1879) and Anglo-Boer Wars (1880-1881 and 1899-1902). The colonizers 
suppressed and dominated the black South Africans (Shillington 2005). 
During this period, a large population of indentured laborers was brought in from India to 
work in the sugar cane industry, along with black migrant workers from rural areas of KZN. 
In 1893 Mahatma Gandhi arrived in Durban to serve as a legal adviser for an Indian law 
firm. The widespread denial of civil liberties and political rights to Indian immigrants 
inspired his struggle for Indians’ rights there and in India. By the end of the 19th century, 
industry, especially mining, used coercive tactics to maintain inexpensive black labor in the 
cities. Over time, this severely disrupted traditional family structures and eroded the rural 
agricultural economy of black South Africans, further increasing the income disparity 
(Coovadia et al. 2009). 
Eventually, South Africa fell under British rule upon signing the peace treaty of Vereeniging 
in 1902. Following unification of the Boer and British colonies, several government policies 
were enacted to entrench white supremacy and racial segregation in South Africa. Racial 
classification with whites at the top resulted in social separation, political exclusion, 
economic marginalization, and racial injustices (Marks and Andersson 1987; WHO 1983). In 
HIV Prevalence (%) 
> 3.0
1.3 - 3.0
0.6 - 1.3
0.3 - 0.6
0.1 - 0.3
<0.1
Interstate highway 285 
surrounds city of Atlanta 
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1923, the African National Congress was formed to peacefully lobby for equal rights for all 
races. Their efforts were largely unsuccessful, as segregation policies were consolidated 
under the right-wing National Party when it rose to power in 1948, which marked the 
official beginning of apartheid. Nelson Mandela, along with many leaders of the ANC, was 
arrested and imprisoned in 1964. Domestic and international pressure finally resulted in the 
demise of apartheid in 1990, and the first free elections were held in South Africa in 1994, 
ushering in a new era with Mandela as president. 
Students and staff from the University of Natal, founded in 1910 in Durban, actively 
protested apartheid policies. In 1950, the first medical school for black students in South 
Africa was established nearby, later named the Nelson Mandela School of Medicine. The 
University of Durban-Westville was created in the 1960s with the express intent of 
providing higher education for students of Indian origin. After the fall of apartheid, these 
universities merged to form the University of KwaZulu-Natal in 2004, which remains one of 
the premier academic institutions in South Africa. UKZN sponsors several prominent 
HIV/AIDS-related research programs that are ongoing today. 
3.2 HIV epidemic in Durban and KwaZulu-Natal 
Sub-Saharan Africa carries a disproportionate burden of HIV infections when compared to 
other regions in the world. Based on two national surveys published in 2008 and 2009, South 
Africa, and specifically the province of KwaZulu-Natal, are at the epicenter of the HIV 
epidemic with HIV prevalence estimates ranging from 15.8% among the general population 
over age 2 to 40% among women presenting to antenatal clinics (Health 2009; Shisana et al. 
2009) (see Figure 2). With such a considerable prevalence, the odds of having a partner with 
 
 
Fig. 2. HIV prevalence by district in South Africa, antenatal clinics, 2008 (Health 2009) 
Durban 
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HIV are high, and this has overwhelmed current prevention efforts aimed at discordant 
couples. In addition to wealth and income disparities, various historical, cultural and 
political factors have directly and indirectly contributed to these substantial rates. 
Until 1988, HIV in South Africa was largely restricted to the homosexual community and 
hemophiliacs who had received blood transfusions (Abdool Karim et al. 2009; Abdool 
Karim and Abdool Karim 2005). However, from that point onward, heterosexual 
transmission became the dominant mode of HIV transmission in South Africa. Using fear, 
stigma and risk profiling, the apartheid government added to pre-existing prejudices 
against homosexuals and blacks. After an initially slow introduction of HIV into the 
heterosexual community, the numbers of individuals with HIV infection grew exponentially 
from 1990 to 1994. HIV prevalence in pregnant women increased from 0.8% to 7.6% during 
this period (Ijsselmuiden et al. 1988; Gouws and Abdool Karim 2005). This contributed to a 
significant rise in the number of perinatal infections. By this time HIV finally became a 
government priority and condom distribution increased throughout the country. 
In the subsequent five years, an even more rapid spread occurred throughout South Africa. 
In particular, certain areas of rural KZN experienced substantial increases. The main factors 
identified that fueled the epidemic included migrant laborers, who served as a bridge 
population between urban and rural community networks (Lurie, Williams, Zuma, Mkaya-
Mwamburi, Garnett, Sweat, et al. 2003) and multiple, concurrent partnerships (rural wife 
and town wife). Also, rape and violence against women increased their susceptibility to HIV 
(Jochelson, Mothibeli, and Leger 1991; Lurie, Williams, Zuma, Mkaya-Mwamburi, Garnett, 
Sturm, et al. 2003; Hunter 2005; Wood, Maforah, and Jewkes 1998; Jewkes 2009; Dunkle et al. 
2004). During this time, the Treatment Action Campaign was formed to combat the AIDS 
denialism that had been previously espoused by the government.  
In 2003, ART was introduced into the public sector with funding from the US President’s 
Emergency Plan for AIDS Relief (PEPFAR). It took over 5 years after PEPFAR was 
introduced in South Africa to see decreases in incidence rates, despite one of the largest ART 
rollouts in the world. Presently, life expectancy in KZN is nearly 50 years for women and 49 
years for men (Statistical Release P0302: Midyear population estimates). In response to these 
overwhelming challenges, South Africa’s HIV/AIDS and STI National Strategic Plan was 
launched in 2007 (The HIV/AIDS Country Scorecard 2008; HIV & AIDS and STI Strategic Plan 
for South Africa, 2007-2011 2007). The latest UNAIDS report has shown a sharp decline in 
the incidence among 18 year olds and women 15-24 years old by 2008 (UNAIDS report on 
the global AIDS epidemic 2010). 
Bringing millions of individuals into care for chronic HIV infection has been a major 
challenge for South Africa. Despite a developed health care system (8.0% of GDP is spent on 
health care), the health care system is overwhelmed with the sheer number of individuals 
infected with HIV. With more than 5.6 million people infected with HIV in South Africa, it is 
estimated that only 36% of adults and 54% of children eligible for treatment (based upon 
current WHO criteria that includes CD4 T cells <350 cells/µL) are currently receiving it 
(Coovadia et al. 2009; UNAIDS report on the global AIDS epidemic 2010). In light of this, it 
has been no small feat to have over 970,000 individuals on ART.  
Poverty in the black population created a general deterioration of health for black South 
Africans associated with high communicable diseases and violence-related injuries (Packard 
1989). Today, over 50% of South Africans live in poverty, more than 40% experience food 
insecurity, and unemployment remains high (25%) (Rose and Charlton 2002; Ojikutu, Jack, 
and Ramjee 2007; Statistical Release P0302: Midyear population estimates). Government policies 
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have preferentially benefitted the rich, and this has further increased the overall income gap 
between the wealthy and the poor (Growth, employment and redistribution: a macro-
economic framework 1996). However, even when treatment is provided at minimal or no 
cost, the substantial cost and effort required to travel long distances (and take time away 
from childcare and subsistence living) becomes a tremendous barrier to regular clinic and 
pharmacy attendance. 
The seeds of the present weakened health care system were sown during the early days of 
colonization, and through the apartheid era and beyond, government policies further 
fragmented the health care system. (Coovadia et al. 2009). Traditional healers were 
marginalized, and health care training and delivery was racially segregated; these factors 
resulted in disparities in funding, and the doctor-patient ratio differed along racial lines 
(fewer black providers for more black patients). Similar human resource challenges exist for 
nursing, and this has been compounded by high rates of HIV infection among health care 
workers (Statistics 2007 2007; Shisana et al. 2004). The state overtook missionary hospitals 
that were crucial in the delivery of health care in rural areas and homelands. Also, the 
government contributes nearly 56% of the national health expenditure to public sector 
health care services, which treats 80-85% of the population. Conversely, the remaining 15-
20% of the population in private health care receive 44% of the national health care 
expenditure (McIntyre and Dorrington 1990; Goudge 1999). As the government encouraged 
providers to move to the private sector and removed funding to the public sector, this 
increased out-of-pocket expenses for poor patients, a significant barrier to care. There are 
also discrepancies in quality between the public and private systems (Dennison et al. 2007; 
Schneider et al. 2005; Palmer 1999). Altogether, these factors result in poor integration of 
services (especially tuberculosis diagnosis and treatment, mental health, and substance 
abuse counseling), overcrowding, long waiting lists, provider fatigue, and patient 
dissatisfaction. 
4. Comparing Atlanta and Durban 
Several aspects about the HIV epidemic in both of these cities make them uniquely 
comparable and allow the illustration of various important facets of engagement in care. 
Atlanta and Durban are both mid-sized cities in wealthy countries, yet both are experiencing 
an HIV epidemic out of proportion to the rest of their respective regions (Table 1). There are 
significant disparities of income and education in both cities, which provide some 
explanation for the high prevalence of HIV. A history of racism, substantial migrant and 
transient communities, cultural denialism of sexual practices, and a thriving commercial sex 
trade may also contribute to the transmission of HIV in both cities.  
 
 Atlanta MSA Durban & nearby townships 
Population 5.4 million 10.6 million 
% of population Black 50% 68% 
HIV prevalence >1% 15.8% to 38.7% (KZN) 
Main risk factors for HIV 
transmission 
MSM 
Heterosexual, IDU 
Heterosexual 
 
Table 1. Comparison of population and HIV prevalence of Atlanta and Durban as of 2008 
(CDC 2009; Mangla and Gant 2008; Health 2009; Shisana et al. 2009) 
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Both cities are racially and culturally diverse, which may impede efforts to treat and prevent 
HIV transmission, and both have gone through changes in the laws and sociopolitical 
environment for black individuals through the past fifty years. Martin Luther King, Jr., 
recognized the connection between the struggles of African-Americans and black South 
Africans living under apartheid rule when he said,  
“In this period when the American Negro is giving moral leadership and inspiration to his own 
nation, he must find the resources to aid his suffering brothers in his ancestral homeland. Nor is this 
aid a one-way street. The civil rights movement in the United States has derived immense inspiration 
from the successful struggles of those Africans who have attained freedom in their own nations.” 
(King 1965) 
There are also some notable differences between the Atlanta and Durban. About two-thirds 
of the individuals living with HIV in Atlanta are African-American, but black South 
Africans comprise an overwhelming majority of individuals with HIV in Durban. HIV 
transmission in Atlanta occurs primarily through men having sex with men (51%), followed 
by heterosexual contact (22%), injection drug use, and other means. Transmission in Durban 
is primarily through heterosexual contact. Also in Atlanta, crack cocaine use contributes 
indirectly to the spread of HIV (Metsch et al. 2008), whereas in Durban, drug abuse is not a 
prominent risk factor. In the following three sections, we describe how various institutions, 
clinics and health care systems have identified ways to overcome barriers to HIV health care 
and methods to improve adherence to HIV treatment.  
5. Engaging in care: access, entry, and retention in clinical care 
Based on the social ecological framework, we have identified the three major areas 
impacting engagement in care are individual, interpersonal, and structural factors (Stokols 
1996). Some individual factors that may limit engagement in care include personal health 
beliefs, substance abuse, homelessness, food insecurity, and competing life priorities. 
Interpersonal factors that may limit engagement in care include communication with 
physicians, experiences with health care staff, or the influences of social networks on health 
behaviors. Structural factors include institutional or systemic factors, economic, cultural and 
political factors. The lack of health insurance, changes in insurance status based on 
employment or fluctuations in income, complexity of the health system, and reduction in 
funding for safety net resources may all limit access, entry and retention into care. 
At the political level, local and federal policy has played a pivotal role in the accessibility of 
HIV treatment. Even despite well-intended efforts, government policies can be complicated 
or ineffective at delivering or augmenting health care or fail to provide the necessary 
safeguards for individuals with private insurance. Although it took almost 10 years to enact, 
the Ryan White CARE Act finally passed in 1990 to provide a safety net of HIV/AIDS 
clinical care in the US (HRSA). In South Africa, HIV denialism at the highest levels of 
government, worked against efforts to provide care and reduce transmission, wasting 
valuable time which undoubtedly led to many unnecessary infections and deaths from 
HIV/AIDS (Chigwedere and Essex 2010). 
5.1 Atlanta 
In Atlanta, a patchwork of private providers, hospital clinics, and safety net providers such 
as Grady Memorial Hospital, the Atlanta Veterans Affairs Medical Center, and county 
health departments provide the clinical care for persons infected with HIV. An individual’s 
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access to medical care and antiretroviral therapy depends on the type of insurance they 
have, as well as their ability to navigate the system designated for them. Patients who are 
undocumented (without legal status in the US) rely on the safety nets that have been 
developed, although their obstacles are even greater than those with legal status. Atlanta is 
one of the cities in the US eligible for Ryan White part A funds that are directed to the most 
severely affected EMAs. To qualify for part A funding an EMA must have reported at least 
2,000 AIDS cases in the most recent 5 years and have a population of at least 50,000. These 
Federal funds are then distributed to various sites in the Atlanta EMA by the Ryan White 
executive committee, which is made up of providers, legislators, patient representatives, 
and other community stakeholders. Clinical sites must apply each year to the Ryan White 
funding committee in order to renew their funding. The state-run AIDS Drugs Assistance 
Programs (ADAP) help to cover the cost of antiretroviral therapy as well as other commonly 
prescribed medications for HIV patients, but as of fall 2010, funding for the Georgia ADAP 
fell short of need and a waiting list was created (HIV Care Program: AIDS Drug Assistance 
Program). Individual pharmaceutical companies have now extended assistance for 
antiretroviral medications for eligible patients on the waiting list, but third-party payer 
assistance for medications remains one of the most significant hurdles for uninsured 
patients in care. 
The Infectious Diseases Program (IDP) at Grady Memorial Hospital treats 5,000 of the most 
advanced cases of HIV/AIDS in the Atlanta EMA annually, and it is one of the largest 
outpatient facilities for HIV-positive individuals in the US. For over twenty years, the IDP 
has provided integrated and comprehensive HIV health care with over 12 specialty and 
subspecialty services available on-site including hematology/oncology, neurology, 
hepatology, dental, ophthalmology, dermatology and metabolic disorders. All HIV-positive 
patients admitted to Grady Memorial Hospital are tracked by the Social Services 
department to ensure referral to the appropriate outpatient provider upon discharge and to 
provide support during hospitalization. Other local hospitals and providers can refer 
patients to IDP as well.  
IDP has made distinct efforts to retain patients in care. Certain populations, such as those 
who are substance abusers, homeless, and/or have a psychiatric illness were found to be at 
high risk for virologic failure and subsequent morbidity and mortality from HIV/AIDS. 
These patients have been targeted for participation in the Transition Center, an open-access 
part of IDP in which patients can arrive as a walk-in to see a medical or psychiatric provider, 
attend substance abuse group therapy visits, and see a nutritionist (Cohen et al. 2011). 
Patients who miss appointments at IDP are contacted by “Client Trackers” who reschedule 
appointments. Finally, a number of support groups and case management programs run by 
community-based organizations (AID Atlanta) are available for patients to discuss the issues 
that impact their lives and help patients participate in HIV primary care. Peer navigators, 
mental health counselors, nurses, and pharmacists all serve as part of the treatment team to 
guide patients through the health system and the process of self-care needed for HIV 
management. 
5.2 South Africa 
Despite the substantial challenges facing patients and health care providers detailed above, 
there have been tremendous accomplishments in ART delivery and health outcomes. Many 
programs throughout the country have shown impressive rates of virologic suppression at 
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six months (90-95%) and very low rates of loss to follow up (Boulle et al. 2008; Marconi et al. 
2008). These outcomes have remained outstanding even after several years of treatment 
(Lawn et al. 2008; Rosen, Fox, and Gill 2007). For the small percentage of patients requiring 
second line therapy, a substantial percentage of patients were able to achieve virologic 
suppression thereafter (Fox et al. 2010; Murphy et al. 2010). Although encouraging, most of 
these reports have been from urban clinics with adequate resources to individually and 
programmatically monitor and manage the large volume of patients initiated on ART. 
Unfortunately, early data from rural sites with fewer resources have shown more 
discouraging outcomes (Mutevedzi et al. 2010). Suboptimal adherence to ART has been 
associated with virologic failure (Nachega et al. 2006; Bisson et al. 2008), drug resistance 
(Braithwaite et al. 2006), and death (Wood et al. 2002). 
Although programmatic monitoring has been required to maintain funding support, it has 
simultaneously served as a mechanism to assist clinics in assessing, assuring and improving 
the care delivery processes and quality of the care provided. Some clinical sites have also 
been fitted with electronic medical records and other electronic systems to improve the 
workflow and immediate access to necessary data. Another effective systematic change has 
been the extensive use of counselors, peer navigators, HIV educators and nurses to deliver 
care for patients who are doing well on treatment, particularly in areas where physician 
resources are limited (Sanne et al. 2010; Abdool Karim et al. 2009). This approach, known as 
task shifting, along with down-referral (the decentralization of care to smaller clinics 
without physicians) has been one way to address the limited human resources relative to the 
demand (Long et al. 2011; Matovu et al. 2011; Sanne et al. 2010). This approach is consistent 
with the development of more community-based health centers to improve access, 
especially in rural areas. In addition to treatment monitoring of patients on a stable regimen, 
the role for nurse initiation and complete follow up management of patients on ART (NIM-
ART) is being assessed in a randomized trial and is being discussed at a national level in 
order to expand treatment access (Colvin et al. 2010; Uebel et al. 2011; Fairall et al. 2011). 
Another intervention being used to improve access and retention in care has been the fast-
tracking of patients in desperate need of starting ART (Geng et al. 2011). Similarly, ART 
initiation in the hospital after initial HIV diagnosis and/or a new opportunistic infection 
helps to reduce the barriers experienced when patients are discharged from the hospital. 
This is especially effective when combined with palliative care programs designed to 
address the multiple symptomatic complaints as well as psychosocial and spiritual needs of 
the patient. In a busy clinical program, these issues often get overlooked by providers and 
nurses which can erode trust in the health care team (Sunpath et al. 2011). In East Africa, 
programs with dedicated staff who use aggressive outreach (by using all available means of 
transportation) to search for patients within 30 days of a missed visit ultimately have lower 
lost-to-follow-up rates (Braitstein et al. 2011). 
Since 75% of HIV-infected individuals in South Africa use remedies dispensed by traditional 
healers, it has become increasingly apparent that patients would ultimately benefit from 
bridging the gap between these disciplines (Shuster et al. 2009). Practitioners of western 
medicine are now working with traditional healers to assist in HIV education, counseling 
and testing in the community (Peltzer, Mngqundaniso, and Petros 2006; Traditional healers in 
South Africa trained to encourage people to get tested for HIV 2006). Consequently, this approach 
has been supported by the South African Department of Public Health (Ojikutu, Jack, and 
Ramjee 2007). 
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5.3 Examples of universal health care systems 
Various health care systems and clinical settings have created structures to improve the 
ability of individuals to remain engaged in care. Some health care systems, such as those 
found in the US Department of Defense (DoD), US Department of Veterans Affairs (VA) and 
various European countries, have reduced or eliminated the out-of-pocket expenses for 
patients or have provided financial assistance through the involvement of integrated 
community-based organizations. In the absence of universal health care, some of the 
interventions include the use of patient navigators, such as those implemented in clinics 
across Haiti, comprehensive integrated care centers (the medical home), patient- and family-
focused care, optimal use of electronic medical records for tracking and process 
optimization, community-based specialty care, and interventions specifically targeting drug 
users or other vulnerable subpopulations. 
5.3.1 Vancouver  
In contrast to the US, Canada provides a universal health care system for all its residents 
that covers treatment of HIV. For example, in the province of British Columbia, health care 
and antiretroviral medications are provided free of charge. Almost as important as 
eliminating out-of-pocket expenses, this system has virtually eliminated the administrative 
barriers that accompany similar systems elsewhere when an individual moves in and out of 
various insurance programs. HIV-positive patients must register with the Drug Treatment 
Program (DTP) that is coordinated by the British Columbia Center for Excellence in 
HIV/AIDS. Despite the availability of free health care, investigators in Vancouver found 
that a significant number of HIV-positive individuals still do not use antiretroviral therapy, 
and that 40% of people who died from HIV-related causes never initiated ART (Joy et al. 
2008). They also found that 16% of individuals waited until their CD4 cell count fell below 
50 cells/µl to initiate ART (Joy et al. 2008). The findings in British Columbia demonstrate 
how access to care alone may not result in optimal health outcomes across all HIV-infected 
populations, and that multiple factors must be considered when designing interventions to 
improve health outcomes (Lima et al. 2010; British Columbia Center for Excellence in 
HIV/AIDS). 
5.3.2 Military and VA 
Most health care in the US is delivered by clinics and hospitals that are privately owned and 
operated (community-based, academic, corporate-owned) and a smaller percentage are 
government-based. Since the US is a mixed market system, the payer source is divided 
between self-pay (12.8%) and third party insurance (87.2%). Third party insurance includes 
public insurance (46.4% of the total as Medicare, Medicaid and government employee 
insurance) and private insurance (40.7% of the total) (CMS 2011). Some of the government 
employee programs such as those associated with the DoD and the VA provide universal 
access to care for their participants. When care is received at government facilities or other 
participating facilities, the individual has no (or minimal) out of pocket expenses and does 
not pay premiums or deductibles. Studies have shown that individuals with HIV in these 
programs have outcomes equivalent to those reported in clinical trials with high levels of 
adherence and virologic suppression, as well as low rates of hospitalization and mortality, 
even among individuals with other significant barriers to care (homelessness, poverty, drug 
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use) (Marconi et al. 2010; Guest et al. 2011). Eliminating out-of-pocket expenses and 
streamlining health care may result in improved outcomes for HIV patients, even for 
traditionally marginalized populations. 
5.4 Overcoming the barrier of substance abuse 
HIV and substance abuse have coexisted since the beginning of the epidemic. Not only does 
injection drug use provide a direct pathway for HIV transmission via the use of shared 
blood products, but certain substances, particularly stimulants, have been associated with a 
high frequency of unprotected sex, providing another pathway for HIV transmission. 
Various techniques have been attempted to improve rates of linkage to care among substance 
abusers, such as coordinated substance abuse, mental health, and medical treatment (Korthuis 
et al. 2011; Weiss et al. 2011; Cunningham et al. 2011). Targeted outreach programs designed to 
bring active drug users to engage in medical care have been implemented in many cities in the 
US and Canada, such as Boston, New Haven, New York, and Vancouver. These outreach 
programs often partner with community-based harm reduction organizations to provide the 
needed services in spaces that may be more comfortable for drug users (Cunningham et al. 
2007; Bardsley, Turvey, and Blatherwick 1990). 
For example, in New York City a partnership between Montefiore Medical Center (academic 
medical institution) and CitiWide Harm Reduction (community-based organization) was 
designed to bring HIV-positive drug users into medical care. Medical providers go to single-
room occupancy hotels accompanied by the outreach teams from CitiWide to meet potential 
patients, offer medical services, and educate patients. Immediate needs such as prescriptions 
for acute illnesses may be written for patients during the outreach, and those who are 
interested may be referred for primary care services on-site at either CitiWide’s walk-in 
clinic or Montefiore’s primary care clinic (Cunningham et al. 2007). Investigators found that 
patients were more likely to keep same-day or walk-in appointments at CitiWide’s walk-in 
clinic compared with future appointments at Montefiore (Cunningham et al. 2007). These 
findings emphasize the need to provide care in various ways that facilitate access to care for 
substance users. 
In Massachusetts, a mobile van from the Massachusetts Department of Public Health targets 
men who have sex with men, in order to diagnose HIV earlier and prevent and treat 
sexually transmitted infections. Researchers found that men using the mobile van’s services 
reported a variety of substances used, including substance use during sex, and that 
polysubstance users had higher numbers of male sexual partners, anonymous male sexual 
partners, and male sexual partners met over the internet in the previous year, when 
compared with non-polysubstance users (Mimiaga et al. 2008). These findings indicate that 
mobile van health services are a useful way to target this high-risk group. 
5.5 Test, Link to Care, Plus Treat (TLC-Plus)  
In order to address many of the challenges in the test-to-treat continuum for HIV infected 
individuals, the NIH-funded HIV Prevention Trials Network (HPTN) has started a study 
called TLC-Plus (Test, Link to Care, Plus Treat) in Washington, DC, and Bronx, NY, to 
evaluate the feasibility of a multifaceted approach to HIV prevention. The study includes a 
package of interventions that include expanded HIV testing, linkage to care, initiation of 
ART for those clinically eligible, promotion of high adherence to maintain virologic 
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suppression, and prevention for positives interventions. The study will also assess the 
patient and provider attitudes toward the initiation of ART in early HIV disease. Outcomes 
in the intervention communities (Washington, DC, and the Bronx, NY) will be compared to 
those in the non-intervention communities (Chicago, Illinois, Houston, Texas, Miami, 
Florida and Philadelphia). This study began enrollment in 2011 and results are expected in 
approximately 3 years.   
5.6 Community-based specialty care 
Regular access to a medical provider specialized to treat HIV may be difficult for some HIV-
positive patients, and the US Institute of Medicine has recently identified critical shortages 
in the number of providers specialized to care for HIV-positive individuals (IOM 2011). In 
addition, some patients may feel that attending an infectious diseases specialty clinic carries 
a stigma, and they may avoid care for this reason. One way that health systems have 
circumvented this barrier is to place HIV specialists in community health care settings. For 
example, Montefiore Medical Center, Bronx, NY, has a hospital-based infectious diseases 
clinic, as well as several community-based primary care clinics that manage HIV-positive 
patients by using partnerships between primary care providers and HIV specialists. 
Investigators found, in a retrospective review comparing those who initiated care in the 
hospital-based setting versus the community-based setting, that patients initiated ART at 
similar rates and achieved similar levels of virologic suppression (Chu et al. 2010). The 
findings here suggest this may be a viable way to provide appropriate HIV specialty care for 
patients who may find difficulty accessing more centralized care settings, and this may 
alleviate some of the provider shortages regarding HIV specialists in the US. 
6. Medication adherence 
After overcoming the hurdles associated with navigating the health care system and 
understanding the complexities of their disease, individuals with HIV must maintain perfect 
adherence to difficult regimens requiring multiple doses per day or suffer the consequences of 
HIV drug resistance and disease progression. Overcoming many psychosocial and physical 
discomforts related to the diagnosis and disease are paramount to ensuring a steady pace in 
what would be considered a marathon of necessary therapy. The most common factors 
associated with poor treatment adherence include untreated depression, active substance 
abuse, poor insight into disease and treatment, youth, higher pill burden, more frequent 
dosing and forgetfulness (Nachega et al. 2011). In Sub-Saharan Africa, the cost of ART, lack 
transportation to the health care facility for refills, and pharmacy stock-outs are additional 
barriers; stigma and food insecurity were the most prevalent risk factors for poor adherence 
(Crane et al. 2006; Nachega et al. 2004; Weiser et al. 2003; Weiser et al. 2010). 
Various approaches have been undertaken to include incorporation of religious and 
spiritual counseling, active substance and mental health programs as well as involvement 
with treatment partners and support groups. Finally, ongoing education and novel 
techniques to allow the incorporation of pill-taking into activities of daily living have 
become crucial components for successful HIV treatment. 
6.1 United States 
In the US, efforts to improve adherence to antiretroviral drug regimens have focused both 
on individual and structural barriers to optimal adherence. Throughout the past 30 years, as 
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newer HIV drugs are developed and become available on the market, the number of pills 
needed for a successful regimen has decreased. Now, many patients starting their first 
regimen can take a single pill (co-formulated tenofovir/emtricitabine/efavirenz, known as 
Atripla) once a day to achieve virologic suppression. In a meta-analysis of 11 randomized 
controlled trials, adherence to once-daily regimens was better than to twice-daily regimens 
(Parienti et al. 2009). The US DHHS Adult and Adolescent Treatment Guidelines have been 
modified to reflect the impact of barriers to adherence on treatment response, so that 
regimens with fewer pills are recommended over other regimens (DHHS 2011). 
Many HIV clinics have trained staff to counsel patients on medication adherence, which 
includes reviewing all of the medications taken prior to initiating or changing a regimen, 
discussing the main side effects, identifying the best ways to take the prescribed 
medications, and helping patients think about ways to incorporate pill-taking into their lives 
with contextual and designed reminders. Reminders such as alarms or pill boxes may be 
coupled with adherence counseling as they have been shown to enhance adherence (Simoni 
et al. 2006; de Bruin et al. 2010). 
For those who are not able to achieve optimal adherence despite individual counseling, 
some health care systems have developed directly observed therapy (DOT) programs, 
which are modeled on the adherence programs initially developed for tuberculosis therapy. 
The idea behind using DOT for HIV therapy is to reduce the risk of viral drug resistance and 
to achieve virologic suppression, which will provide health benefits to the patient as well as 
reduce the risk of HIV transmission. There are many varieties of DOT programs in practice, 
depending on the needs of the patient population and the services available from the health 
care system. One of the main differences between TB therapy and HIV therapy is that for 
HIV, the duration of therapy is life-long, and the number of pills or frequency of doses may 
not decrease over time. However, the overall benefit of DOT on virologic suppression is 
controversial with studies finding both a lack of benefit and an overall benefit to DOT, with 
respect to adherence, immunologic, and virologic outcomes (Hart et al. 2010; Myers and 
Tsiouris 2009; Ford et al. 2009). 
One example of a patient-centered DOT program can be found in New York City. Due to the 
barriers to adherence faced by opioid-dependent HIV-positive patients, a DOT program for 
HIV therapy was developed to deliver HIV medications at methadone clinics. US federal 
policies require patients to obtain their methadone doses from one clinic, and at the 
discretion of the clinic, patients may be required to attend daily or weekly observed dosing 
appointments. Since the patients may visit the methadone clinic frequently (every day, or at 
least five to six days per week), HIV medications were coupled with the observed daily 
methadone dose. Investigators found that patients in the DOT program achieved higher 
levels of adherence and virologic suppression when assessed after 24 weeks (Berg et al. 
2011). 
Contingency management, which consists of financial incentives for medication adherence, 
has also been shown to be efficacious in enhancing participation in substance abuse 
treatment and for reducing drug use. The use of contingency management for HIV has been 
shown to be effective (Petry et al. 2010), but the beneficial effect appears to wane after 
incentives are removed (Rosen et al. 2007). Future studies that incorporate contingency 
management, patient navigators, and/or peer counseling will need to be tested before 
contingency management can be considered as a “best practice” for the management of 
HIV.  
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6.2 Sub-Saharan Africa 
The World Health Organization established several Early Warning Indicators in order to 
identify how well sites are managing ART usage and adherence. These have directly 
resulted in optimization of the quality of care and have assisted in the identification of 
vulnerable clinics (Jordan et al. 2011; Hong et al. 2010). A significant effort has been applied 
to ensuring high rates of adherence in various clinics throughout Africa and in particular 
South Africa (Mills et al. 2006). Individual adherence sessions with peer counselors and 
group education programs provide detailed information on HIV infection, antiretroviral 
medications, drug interactions, stigma, and adherence techniques (Lawn et al. 2007; Matovu 
et al. 2011). Many of these programs and support groups work to increase social capital and 
empower individuals to make health a priority (Achieng et al. 2011). Individuals who do not 
disclose their HIV status to intimate partners or household members may feel stigmatized 
and hide their pills for fear of being discovered, and disclosure of HIV status has been 
proven to improve adherence (Nachega et al. 2004). In Kenya, mobile phone text messages 
improved ART adherence over standard care (Lester et al. 2010; Pop-Eleches et al. 2011). 
Various methods of adherence monitoring have been evaluated to determine efficacy 
(Nachega et al. 2011). Pill counts (Achieng et al. 2011) and pharmacy refill monitoring 
(Murphy et al. 2011) have been shown to be reliable and inexpensive but not consistent 
across all settings. Directly observed ART has also been examined with mixed results but 
overall is costly and labor intensive (Nachega et al. 2010; Hart et al. 2010), as is therapeutic 
drug monitoring via plasma or hair sampling (van Zyl et al. 2011). 
6.3 Haiti 
In rural Haiti, a non-governmental organization, Partners in Health, has been working since 
1987 to support HIV/AIDS treatment. Among the many barriers to optimal care in Haiti, i.e. 
poverty, food insecurity, political disruptions, a program was developed to help HIV 
patients take their medications. Accompagnateurs, or community health workers, were 
people chosen from the local community and trained in medication and symptom 
management for HIV patients. Since starting this program, patients have experienced an 
increase in CD4 count and reduction in viral loads, and therefore the accompagnateurs have 
been identified as a critical component of the clinical care provided for these patients 
(Koenig, Leandre, and Farmer 2004; Behforouz, Farmer, and Mukherjee 2004). 
7. Improving social capital 
One important factor to HIV-positive patients achieving optimal health is the ability to 
leverage social capital. Social capital can be defined as the value that comes from 
engagement in a social network. Social capital can help HIV patients achieve good health by 
providing psychological and physical support (e.g. food, shelter, transportation, money for 
medications). Stigma can inhibit the ability to leverage social capital because it interferes in 
the individual’s willingness to seek help from others in their social network (Bangsberg and 
Deeks 2010). In a qualitative study conducted in Kenya, Uganda, and Nigeria, researchers 
found that higher levels of social capital helped HIV-positive patients to prioritize ART 
adherence and achieve improved health (Ware et al. 2009). 
A substantial impact has occurred via the implementation of outreach programs designed to 
improve the social capital of various disenfranchised populations where stigma, poor health 
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literacy and lack of education stymie those already challenged by competing priorities. 
Different forms of outreach have been developed, specific to the needs of the marginalized 
population. These programs have attempted to improve engagement in care and to support 
those who are living with HIV. For example, programs in Boston (PACT – Prevention, 
Access to Care and Treatment), San Francisco (PHAST – Positive Health Access to Services 
and Treatment), and New York City (St. Luke’s-Roosevelt Hospital Center’s Center for 
Comprehensive Care) have designed successful outreach programs targeting the patients 
with the worst levels of engagement in care (Rosenberg 2011). The Community Health Care 
Van in New Haven provides prevention and treatment services for HIV, hepatitis, substance 
abuse, and mental illness from a medical van (HRSA). By focusing on the needs of the whole 
patient, including shelter, food, mental health, and medical comorbidities, and helping them 
to capitalize on available services and social capital, these programs have helped some of the 
most vulnerable patients successfully treat their HIV infection. 
8. Conclusion 
If every HIV-infected individual could know their diagnosis, enter the health care system, 
start antiretroviral therapy when appropriate and incorporate all the evidence-based 
preventive health measures into his or her life, we could potentially see a world free of HIV 
within generations. This is the premise behind the “Test and Treat” strategy (Granich et al. 
2009). While this may seem to be a lofty goal, the examples presented here from Atlanta and 
Durban, as well as those from many other places around the world, suggest that even if the 
economic resources were made available to implement the “Test and Treat” strategy, there 
are individual, interpersonal, and structural-level barriers that could limit the impact of such 
approach (Gardner et al. 2011). 
In order to combat the disparities in HIV infection rates and HIV-related morbidity and 
mortality, creative solutions are necessary. This chapter describes the comparison between 
the response to the HIV epidemic between Atlanta and Durban, highlighting important 
similarities and differences between the two cities. Both Atlanta and Durban are located in 
wealthy countries, yet both have significant racial/ethnic and socioeconomic factors that 
have led to continued HIV transmission and disparities in HIV outcomes. In each city, 
individual programs have designed solutions to improve diagnosis and engagement in care. 
In addition, several other programs around the world have developed their own responses 
to the HIV epidemic, to deliver care to those who need it within their local contexts. 
Focusing on marginalized subpopulations, while difficult, is important both for reducing the 
disparities in HIV infection and outcomes and also for reducing community-level viral load 
and subsequent transmission of the virus. These subpopulations of patients may require 
more intensive resources or specific interventions that successfully engage them in care. For 
example, several different types of programs in the US, such as targeted outreach in mobile 
vans, DOT, and variations on the specialty clinic model, have successfully engaged 
marginalized patients in care. In South Africa, systemic solutions (such as actively seeking 
out patients who miss appointments and expanding the roles of allied health professionals) 
and cultural solutions (such as incorporating traditional healers into medical care) are being 
used to improve engagement in care and ART adherence. 
As HIV continues to spread, and as patients live longer, health systems must develop 
strategies for HIV prevention and continued engagement in care; this will undoubtedly 
www.intechopen.com
 
Social Determinants of HIV Health Care: A Tale of Two Cities 
 
49 
require flexibility and new ideas to be tested and implemented. HIV has been touted as now 
being a chronic disease, but we must remember that it is an infectious chronic disease. If 
those infected with HIV have detectable virus circulating in the bloodstream and mucosal 
surfaces, transmission will continue to occur. Thus, until there is a cure, retaining patients in 
HIV care over a lifetime is a major challenge for any health care system, particularly for 
regions that lack universal access to care. Health systems’ solutions will also need to address 
the individual, interpersonal, and underlying structural factors that lead to HIV 
transmission and the disparities in access to health care. As low- and middle-income 
countries scale up HIV treatment services, these health systems can serve as models for 
management of non-communicable diseases as well (Rabkin and El-Sadr 2011). Multiple 
layers of co-occurring interventions that target individual-level, interpersonal-level, and 
structural-level factors would address the many aspects of optimal HIV prevention and 
therapy.  
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